Archives for March 13, 2013

← 2013

Chromadex cements position in NR market with third IP acquisition

By Hank Schultz

Chromadex has announced a licensing deal with Washington University in St. Louis for the worldwide exclusive patent rights related to the recently discovered vitamin nicotinamide riboside (NR). It is Chromadex’s third IP acquisition related to the molecule.